2008
DOI: 10.1109/memb.2007.913849
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac cell therapy in vitro: reproducible assays for comparing the efficacy of different donor cells [Cellular/Tissue Engineering]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
30
0

Year Published

2008
2008
2014
2014

Publication Types

Select...
8
1

Relationship

6
3

Authors

Journals

citations
Cited by 19 publications
(30 citation statements)
references
References 43 publications
0
30
0
Order By: Relevance
“…3, C and D), it remains unknown to what degree and over what spatial scales coupling between host cardiomyocytes and electrically passive (17,34), immature (13,47), or heterogeneous (16,17) donor cells would be safe and advantageous for functional improvements in heart disease. Systematic studies in micropatterned cocultures of cardiomyocytes and other cell types, similar to those by Bursac et al (8,9,22), could be used to further address these questions.…”
Section: Discussionmentioning
confidence: 99%
“…3, C and D), it remains unknown to what degree and over what spatial scales coupling between host cardiomyocytes and electrically passive (17,34), immature (13,47), or heterogeneous (16,17) donor cells would be safe and advantageous for functional improvements in heart disease. Systematic studies in micropatterned cocultures of cardiomyocytes and other cell types, similar to those by Bursac et al (8,9,22), could be used to further address these questions.…”
Section: Discussionmentioning
confidence: 99%
“…To assess the role of connexin isoform in electrotonic loading of cardiomyocytes by unexcitable cells, we expressed connexin-43 or connexin-45 and different fluorescent reporters in HEK-293 cells (CRL-1573, American Type Culture Collection), as previously described (21). Specifically, the rat connexin-43 gene (GJA1) was cloned from neonatal rat cardiac myocytes using primers based on the published rat connexin-43 sequence (PubMed NM_012567), and the amplified PCR product was inserted into a cloning vector and validated by DNA sequencing.…”
Section: Cell Culturementioning
confidence: 99%
“…24,32 The standard, highly cardiomyocyteenriched cell suspension was obtained after two preplating steps, during which the faster-attaching non-cardiomyocytes (i.e., fibroblasts 30,32 ) were discarded. The cells were diluted in our standard cell seeding…”
Section: Cell Culturementioning
confidence: 99%